PMC:7784786 / 6951-7121 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"237","span":{"begin":19,"end":29},"obj":"Chemical"}],"attributes":[{"id":"A237","pred":"tao:has_database_id","subj":"237","obj":"MESH:C000597346"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ht side. (D) After itolizumab (48 h): radiological improvement with significant decrease of the alveolar interstitial infiltrate of both lungs.\nFigure 2. Circulating bio"}

{"project":"LitCovid-sentences","denotations":[{"id":"T63","span":{"begin":144,"end":153},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ht side. (D) After itolizumab (48 h): radiological improvement with significant decrease of the alveolar interstitial infiltrate of both lungs.\nFigure 2. Circulating bio"}